Drug Report History #97274
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v14-EN | Version v7-FR |
|---|---|---|
| Language | English (Updated) | French |
| Date Updated | 2019-12-19 (Updated) | 2019-12-11 |
| Drug Identification Number | 02305941 | 02305941 |
| Brand name | STALEVO | STALEVO |
| Common or Proper name | STALEVO FCT 100MG 100'S | STALEVO FCT 100MG 100'S |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC | NOVARTIS PHARMACEUTICALS CANADA INC |
| Ingredients | ENTACAPONE CARBIDOPA LEVODOPA | ENTACAPONE CARBIDOPA LEVODOPA |
| Strength(s) | 200MG 25MG 100MG | 200MG 25MG 100MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | 100'S | 100'S |
| ATC code | N04BA | N04BA |
| ATC description | DOPAMINERGIC AGENTS | DOPAMINERGIC AGENTS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2019-10-24 | 2019-10-24 |
| Estimated end date | 2019-12-17 (Updated) | 2019-12-13 |
| Actual end date | 2019-12-18 (Updated) | |
| Shortage status | Resolved (Updated) | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Supply interruption | Supply interruption |
| Health Canada comments |